A private cancer treatment provider, which last year opened a community diagnostic hub in partnership with an NHS […]

It’s been 12 years since the UK government set out their vision for patients having greater involvement in […]

New facility opens on the Cambridge Research Park offering pharmaceutical development services

Enhertu reduced the risk of disease progression or death compared to chemotherapy in certain patients with metastatic breast […]

Sepsis is a life threatening organ dysfunction caused by a dysregulated response to infection.1 Early treatment with appropriate […]

Looking backA jubilee gives us all an excuse for looking back. In the case of the Platinum Jubilee […]

Two or three drinks every day could put your liver in danger. Using proteomics and machine learning, researchers […]

Researchers have developed 3D printed artificial heart valves designed to allow a patient’s own cells to form new […]

A scientist comments on the evolving treatment of rectal cancer in light of findings from a study that […]

Combination chemoimmunotherapy with the Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib demonstrated improved progression-free survival over standard chemoimmunotherapy for […]